Recent Updates
Recently added Catalysts
CDNA Positive Sentiment

CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026

Thursday, October 15, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: CareDx, Inc. has announced that it will report its financial results for the third quarter of 2026 on October 29, 2026. The report will be released after market close, followed by a webcast and conference call at 1:30 p.m. PT. This event will provide insights into the company's performance and future outlook.

Market Sentiment Analysis

POSITIVE FACTORS

  • CareDx is a leading precision medicine diagnostics company.
  • The upcoming financial results may indicate positive growth.
  • The company is actively engaging with investors through a conference call.

Full Press Release Details

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced it will report financial results for the third quarter 2026 after market close on Thursday, October 29, 2026. The Company will host a webcast and conference call that day at 1:30 p.m. PT / 4:30 p.m. ET. A live and archived webcast of the conference call can be accessed on the Events & Presentations section of C

Frequently Asked Questions

When will CareDx report its Q3 2026 financial results?

CareDx will report its Q3 2026 financial results on October 29, 2026.

What time is the CareDx conference call?

The CareDx conference call is scheduled for 1:30 p.m. PT / 4:30 p.m. ET.

How can I access the CareDx conference call?

The conference call can be accessed via a live and archived webcast on their website.

What is CareDx known for?

CareDx is a leading company in precision medicine diagnostics, focusing on transplant and oncology.

ShareAdd on Google
Tags: CDNA CareDx financial results conference call October 2026
Last updated: Oct 15, 2026

Biotech snapshot

Cash runway
$374M liquidity · $0M/mo burn
Low dilution risk